There is no doubt that a migraine could turn your whole day upside-down. But, taking the right medication and timely treatment could save your from suffering.
As per studies migraine is the most frequent cause of more than 800,000 cases of emergency within the United States annually. Additionally, it is advised to take prescription medications that are approved by FDA and recommended by medical professionals.
At present, there are two oral medications accepted by the FDA for treating migraines that occur in a series. They are Nurtec ODT and Qulipta. This article will give you Qulipta Review and more detailed information about the product. Keep reading to find out more.
What is Qulipta?
Qulipta is among two oral medicines used to treat intermittent migraines in the event of which is accepted through FDA (FDA) Food and Drug Administration in the United States.
Following the time that Nurtec ODT, also called Rimegepant which was approved in 2020. Qulipta was the 2nd medication (atogepant) recognized as the oral anti-calcitonin drug and gene-related peptide to treat migraine. It is also an prescription medication designed for adults. It is however unclear if it is given to children.
In the next section in the coming section, we will focus more details on the Qulipta Review which will include the people who should be taking it and the adverse effects of the drug.
Who Should Avoid Qulipta?
It is suggested for people to talk with a medical professional the situation of any of the following ailments:
- If you’re on dialysis or have kidney issues, you should consider it.
- Patients suffering from liver problems
- Women who are pregnant or breastfeedingor who are planning to be pregnant.
It is not recommended to take together with other medicines such as:
- St. John’s Wort
- Ketoconazole / Itraconazole
What Are The Side Effects of Qulipta?
Like many other drugs, Qulipta may have some adverse effects, including:
Qulipta Reviews – What is The Patient Feedback?
Based on the research, Qulipta has an overall 4.2-star rating out of five. However, reviews aren’t all positive, and includes both positive and negative reviews.
One person who is 28 years old older and suffers from migraine describes the medication to be a remarkable treatment for her. She says that none of the other treatments, such as occipital nerve blocks, were efficient. Although she was dizzy initially however, she was prescribed medication over 2.5 months. This proved successful.
However another user claims that they began with Qulipta 60 mg daily. While they did not experience migraine the first week and were dizzy, by the end of the fourth week, they experienced a migraine again. Based on Qulipta Review the patient claims that they been diagnosed with Covid prior to taking the medication. They suggest giving another try before making the switch.
However, some users have reported dizziness from the beginning and have praised its effectiveness. So, it is suggested that patients talk to their physician and read the reviews thoroughly before deciding to take the treatment. It is important to note that all information and data is taken from websites, and we have no authority on the subject.